Kaytus-LS Syrup is a multi-ingredient formulation combining Levosalbutamol (1mg/5ml), Ambroxol (30mg/5ml), Guaifenesin (50mg/5ml), and Menthol (2.5mg/5ml) designed to provide comprehensive relief from respiratory conditions characterized by bronchospasm, mucus hypersecretion, and cough. Levosalbutamol, a selective β2-adrenergic receptor agonist, acts as a bronchodilator to relax bronchial smooth muscle, thereby alleviating bronchoconstriction and improving airflow. Ambroxol serves as a mucolytic agent, facilitating the breakdown and clearance of viscous mucus from the respiratory tract, enhancing expectoration. Guaifenesin functions as an expectorant, promoting the hydration of airway secretions to ease mucus clearance. Menthol provides a soothing effect on the respiratory mucosa and contributes to symptomatic relief by producing a cooling sensation that may reduce cough reflex sensitivity. Kaytus-LS Syrup is indicated for the management of acute and chronic bronchitis, asthma exacerbations, and other obstructive airway diseases where bronchospasm and mucus retention are prominent. The combination therapy targets multiple pathophysiological aspects of respiratory distress, improving patient comfort and respiratory function. Use should be guided by a healthcare professional, considering contraindications and potential drug interactions.